We are live on ! Find out more
MBOT icon

Microbot Medical

33 hedge funds and large institutions have $3.39M invested in Microbot Medical in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 3

3% less funds holding

Funds holding: 3433 (-1)

14% less capital invested

Capital invested by funds: $3.94M → $3.39M (-$555K)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
14
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q4 2015 in Review

33 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2015, worth a combined $3.39M — down 14% from $3.94M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MBOT and 5 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 14 added.

The largest buyer was Citadel Advisors, adding an estimated $60.2K. The largest seller was Sabby Management, cutting an estimated $841K.

  • 33 institutional investors held Microbot Medical (MBOT) as of Q4 2015, down from 34 in Q3 2015.
  • Funds reported $3.39M of Microbot Medical stock for Q4 2015, down 14% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q4 2015 and 6 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q4 2015 was Citadel Advisors, an estimated $60.2K added.
  • The largest Microbot Medical seller in Q4 2015 was Sabby Management, an estimated $841K sold.

Based on aggregated 13F filings for Q4 2015.